AI-supported mammography screening reduces advanced breast cancer rates and improves early detection, according to the largest randomized controlled trial to date.
Key Details
- 1Over 100,000 Swedish women were randomized to AI-supported vs. standard double-reading mammography screening.
- 2AI-supported screening resulted in a 12% reduction in interval (between-screening) breast cancer diagnoses.
- 316% fewer invasive, 21% fewer large, and 27% fewer aggressive subtype cancers were identified in the AI arm.
- 481% of cancers were detected at screening with AI, versus 74% in the control group—a 9% increase.
- 5False positive rates were similar between groups (1.5% AI, 1.4% control), and radiologist workload was reduced by 44% in interim analyses.
- 6The study supports use of tested AI tools as an aid—not a replacement—for radiologists, especially amid workforce shortages.
Why It Matters
This landmark trial shows substantial clinical benefit and workflow relief from using AI in breast cancer screening, supporting adoption in radiology programs facing growing patient volumes and staff shortages. The findings may shape future screening guidelines and training requirements for imaging AI use.
Source
EurekAlert
Related News
•EurekAlert
AI Tool Predicts Risks for Cancer Patients After Heart Attack
A new AI-powered risk prediction model assists clinicians in treating cancer patients following a heart attack by combining oncology and cardiovascular data.
•EurekAlert
Intelligent Medicine Journal Rises in International Influence Rankings
Intelligent Medicine ranks 66th in China's top internationally influential journals, reflecting its impact in AI-driven clinical research.
•EurekAlert
Natural-Looking Adversarial Images Could Strengthen Medical AI Security
Japanese researchers introduce IFAP, a new technique that generates natural-looking adversarial images to more effectively test and improve AI vision systems.